Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (NCT07167537) titled 'A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases' on Sept. 10.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Beijing GoBroad Hospital
Condition:
Systemic Sclerosis (SSc)
Primary Sjogren'
s Syndrome
Intervention:
Biological: OL-CD19-GDT
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: October 2025
Target Sample Size: 44
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07167537
Disclaimer: Cu...